Clinical Cancer Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Current Issue

Volume 28,

Issue 13

1 July 2022

View This Issue

About the Journal

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; gene therapy; diagnostic biomarkers; innovative imaging, and clinical genetics. Read More About the Journal

Editor-in-Chief

Keith T. Flaherty

View Full Editorial Board

Impact Factor

13.801

SUBMIT TO JOURNAL

Featured Articles

Clinical Trials: Targeted Therapy

Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia

Marina Konopleva, et al.

CCR Translations

Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer

Shih Yu Cindy Yang; Trevor J. Pugh; Amit M. Oza

CCR Translations

What's in a Name? That Which We Call Immune Cells by Any Other Name Would All Smell as Sweet

Roberto Salgado; Sherene Loi

Trending - Altmetric

Immune Escape Mechanisms as a Guide for Cancer Immunotherapy

Last mentioned on Tuesday July 5 2022

Spatial and Transcriptomic Analysis of Perineural Invasion in Oral Cancer

Last mentioned on Tuesday July 5 2022

Rb tumor suppressor in small cell lung cancer: Combined genomic and immunohistochemical analysis with a description of a distinct Rb-proficient subset.

Last mentioned on Wednesday July 6 2022

Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL—Response

Last mentioned on Friday July 1 2022

Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma

Last mentioned on Friday July 1 2022

Latest
Most Read
Most Cited

Agonizing over the stimulatory immune checkpoint ICOS

Biological misinterpretation of transcriptional signatures in tumour samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data

Rb tumor suppressor in small cell lung cancer: Combined genomic and immunohistochemical analysis with a description of a distinct Rb-proficient subset.

A cathepsin targeted quenched activity-based probe facilitates enhanced detection of human tumors during resection

Tweets by CCR_AACR

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept